2018–2019 Drug Updates in Solid Tumors
Presented by Sally Barbour, PharmD, BCOP, CPP, FHOPA
From Duke University Hospital, Durham, North Carolina
Presenter’s disclosure of conflicts of interest are found at the end of this article.
J Adv Pract Oncol 2020;11(3):255–258 |
© 2020 Harborside™
Sally Barbour, PharmD, BCOP, CPP, FHOPA, updated attendees on the FDA-approved therapies for initial or expanded indications for solid tumors across the past year, as well as their supporting clinical trial data and best practices for safe and effective dosing and administration, drug monitoring, and adverse event management.
For access to the full length article, please sign in